Michael Powell's Net Worth

$5.25 Million

Estimate Recalculated Sep 29, 2025 08:01PM EST

Who is Michael Powell

Michael Powell has an estimated net worth of $5.25 Million. This is based on reported shares across multiple companies, which include AMARIN CORP PLC\UK, COTHERIX INC, Orexigen Therapeutics, Inc., Trius Therapeutics Inc, CORGENTECH INC, HYPERION THERAPEUTICS INC, MARINUS PHARMACEUTICALS INC, HISTOGENICS CORP, Vera Therapeutics, Inc., Aclaris Therapeutics, Inc., AERIE PHARMACEUTICALS INC, Inozyme Pharma, Inc., KALOBIOS PHARMACEUTICALS INC, Entasis Therapeutics Holdings Inc., Iterum Therapeutics plc, Checkmate Pharmaceuticals, Inc., Galera Therapeutics, Inc., Bolt Biotherapeutics, Inc., Principia Biopharma Inc., NextCure, Inc., Mirna Therapeutics, Inc., THRESHOLD PHARMACEUTICALS INC, aTYR PHARMA INC, ALIMERA SCIENCES INC, Akouos, Inc., NOVACEA INC, Durata Therapeutics, Inc., Versartis, Inc., SEATTLE GENETICS INC /WA, Anthera Pharmaceuticals Inc, Spark Therapeutics, Inc., and Ocera Therapeutics, Inc..

SEC CIK

Michael Powell's CIK is 0001202793

Past Insider Trading and Trends

2006 was Michael Powell's most active year for acquiring shares with 7 total transactions. Michael Powell's most active month to acquire stocks was the month of May. 2006 was Michael Powell's most active year for disposing of shares, totalling 4 transactions. Michael Powell's most active month to dispose stocks was the month of August. 2016 saw Michael Powell paying a total of $15,080.94 for 34,469 shares, this is the most they've acquired in one year. In 2022 Michael Powell cashed out on 70,030 shares for a total of $0.00, their largest year based on trade value.

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AMARIN CORP PLC\UK

Investor

Updated Mar 31, 2011


Form 4	-4.75%	-424.90K	$7.25	-$3.08M	Mar 31, 2011	8.51M	Sale	—	Mar 29
Form 4	-6.05%	-575.10K	$7.55	-$4.34M	Mar 28, 2011	8.94M	Sale	—	Mar 24 - Mar 25
Form 4	-17.37%	-2.00M	$7.50	-$15.00M	Mar 14, 2011	9.51M	Sale	—	Mar 11
Form 4	-5.24%	-637.00K	$7.26	-$4.62M	Mar 11, 2011	11.51M	Sale	—	Mar 09 - Mar 10
Form 4	-2.90%	-363.00K	$8.13	-$2.95M	Mar 01, 2011	12.15M	Sale	—	Feb 25
Form 3	—	—	—	—	Dec 30, 2010	12.51M	—	—	—


Form 4	5.15%	115.78K	—	—	Oct 21, 2004	2.40M	Options	—	Oct 20
Form 4	252.10%	358.43K	$6.00	$2.15M	Oct 19, 2004	539.99K	Purchase	—	Oct 15
Form 3	—	—	—	—	Oct 15, 2004	181.57K	—	—	—


Form 4	—	20.00K	—	—	Jun 06, 2011	20.00K	Grant	—	Jun 02
Form 4	-55.99%	-825.00K	$8.26	-$6.84M	Dec 23, 2010	648.60K	Sale	—	Dec 21 - Dec 23
Form 4	-18.77%	-456.25K	$8.63	-$3.91M	Dec 21, 2010	1.98M	Sale	—	Dec 17 - Dec 20
Form 4	—	20.00K	—	—	May 28, 2010	20.00K	Grant	—	May 27
Form 4	-35.33%	-700.00K	$6.13	-$4.29M	Mar 19, 2010	1.28M	Sale	—	Mar 17 - Mar 19
Form 4	-16.80%	-400.00K	$9.18	-$3.67M	Sep 11, 2009	1.98M	Sale	—	Sep 10
Form 4	-14.38%	-400.00K	$8.00	-$3.20M	Aug 13, 2009	2.38M	Sale	—	Aug 12
Form 4	—	12.50K	—	—	May 29, 2009	12.50K	Grant	—	May 27
Form 4	-0.03%	-700.00	$12.09	-$8.46K	Sep 02, 2008	2.78M	Sale	—	Aug 29
Form 4	-1.10%	-30.80K	$12.05	-$371.13K	Aug 29, 2008	2.78M	Sale	—	Aug 27 - Aug 28
Form 4	-0.36%	-10.10K	$12.00	-$121.21K	Aug 25, 2008	2.81M	Sale	—	Aug 21 - Aug 25
Form 4	—	25.00K	—	—	Jun 12, 2008	25.00K	Grant	—	Jun 10
Form 4	-50.00%	-2.82M	—	—	May 03, 2007	2.82M	Options	—	May 01
Form 3	—	—	—	—	Apr 25, 2007	—	—	—	—


Form 4	—	—	$1.29	$12.00K	Mar 27, 2012	9.30K	Options	—	Mar 26
Form 4	-5.75%	-6.90K	$5.59	-$38.56K	Jan 20, 2012	113.13K	Sale	Scheduled	Jan 18 - Jan 19
Form 4	-17.03%	-24.62K	$5.44	-$133.99K	Jan 17, 2012	120.03K	Sale	Scheduled	Jan 13 - Jan 17
Form 4	-96.00%	-3.47M	—	—	Jan 17, 2012	144.65K	Disposition	Scheduled	Jan 12
Form 4	—	12.00K	—	—	Jun 06, 2011	12.00K	Grant	—	Jun 02
Form 4	—	12.00K	—	—	Nov 05, 2010	12.00K	Grant	—	Nov 03
Form 3/A	—	—	—	—	Aug 18, 2010	—	—	—	—
Form 4	-69.68%	-12.66M	$4.68	$8.06M	Aug 10, 2010	5.51M	Buy-Options	—	Aug 06
Form 3	—	—	—	—	Aug 02, 2010	—	—	—	—


Form 4	—	10.00K	—	—	May 12, 2008	4.92M	Grant	—	May 09
Form 4	—	3.70M	$4.05	$15.00M	Dec 18, 2007	4.91M	Purchase	—	Dec 18
Form 4	—	10.00K	—	—	May 31, 2007	1.21M	Grant	—	May 31
Form 4	—	1.00	$6.86	$6.86	Aug 16, 2006	1.20M	Purchase	—	Aug 15
Form 4	—	7.50K	—	—	Jun 23, 2006	1.21M	Grant	—	Jun 22
Form 4	4,642.03%	1.23M	—	—	Dec 19, 2005	1.25M	Grant	—	Dec 15 - Dec 16
Form 3	—	—	—	—	Dec 19, 2005	26.31K	—	—	—


Form 4	-100.00%	-1.94M	$46.00	-$89.22M	May 08, 2015	—	Disposition	—	May 07
Form 4	-17.72%	-417.75K	$27.70	-$11.57M	Jun 06, 2014	1.94M	Sale	—	Jun 04
Form 4	-20.02%	-590.00K	$30.02	-$709.22K	Mar 05, 2014	2.37M	Sale	Scheduled	Mar 03 - Mar 04
Form 4	18.73%	408.39K	$10.00	-$1.03M	Aug 02, 2012	2.96M	Purchase	—	Jul 31
Form 3	—	—	—	—	Jul 25, 2012	15.79K	—	—	—


Form 4	-35.31%	-750.68K	$1.39	-$1.04M	Oct 24, 2016	1.38M	Sale	—	Oct 20
Form 4	-59.41%	-7.45M	$8.00	$6.01M	Aug 07, 2014	5.09M	Buy-Options	—	Aug 05
Form 3	—	—	—	—	Jul 31, 2014	—	—	—	—


Form 4	30.91%	490.39K	$10.86	—	Dec 10, 2014	2.08M	Purchase	—	Dec 08
Form 3	—	—	—	—	Dec 02, 2014	—	—	—	—


Form 4	33.25%	727.27K	$11.00	—	May 18, 2021	2.91M	Purchase	—	May 18
Form 3	—	—	—	—	May 13, 2021	—	—	—	—


Form 4	-64.71%	-4.20M	$11.00	—	Oct 13, 2015	2.29M	Buy-Options	—	Oct 13
Form 3	—	—	—	—	Oct 06, 2015	—	—	—	—


Form 4	-39.15%	-1.01M	$24.91	-$24.21M	Jul 11, 2014	1.57M	Sale	—	Jul 09 - Jul 10
Form 4	-6.94%	-191.98K	—	—	Jun 04, 2014	2.57M	Disposition	—	Jun 02
Form 4	-10.48%	-323.93K	$16.00	-$5.18M	May 27, 2014	2.77M	Sale	—	May 22
Form 4	-75.75%	-10.12M	$6.49	—	Oct 30, 2013	3.24M	Buy-Options	—	Oct 25
Form 3	—	—	—	—	Oct 25, 2013	—	—	—	—


Form 4	-82.94%	-9.86M	$16.00	—	Jul 28, 2020	2.03M	Buy-Options	—	Jul 28
Form 3	—	—	—	—	Jul 23, 2020	—	—	—	—


Form 4	0.63%	57.16K	—	—	Feb 07, 2013	9.57M	Options	—	Feb 05
Form 3	—	—	—	—	Aug 10, 2012	28.42K	—	—	—


Form 4	-91.12%	-15.79M	$15.00	—	Oct 02, 2018	1.54M	Buy-Options	—	Sep 28
Form 3	—	—	—	—	Sep 25, 2018	—	—	—	—


Form 4	-28.96%	-500.00K	$1.62	-$812.08K	Jun 03, 2020	1.23M	Sale	—	Jun 01 - Jun 02
Form 4	—	1.75M	$1.00	$1.75M	Jan 23, 2020	1.75M	Grant	—	Jan 21
Form 4	40.77%	500.00K	$13.00	—	May 30, 2018	1.73M	Purchase	—	May 30
Form 3	—	—	—	—	May 24, 2018	—	—	—	—


Form 4	-100.00%	-70.03K	—	—	May 31, 2022	—	Disposition	—	May 31
Form 4	—	30.00K	—	—	Aug 10, 2021	30.00K	Grant	—	Aug 09
Form 4	—	10.03K	—	—	Jun 21, 2021	10.03K	Grant	—	Jun 16
Form 4	—	30.00K	—	—	Nov 12, 2020	30.00K	Grant	—	Nov 10
Form 4	-85.51%	-21.29M	$15.00	—	Aug 12, 2020	3.61M	Buy-Options	—	Aug 11
Form 3	—	—	—	—	Aug 06, 2020	—	—	—	—


Form 4	—	64.00K	—	—	Jun 16, 2023	64.00K	Grant	—	Jun 14
Form 4	—	20.00K	—	—	Jun 16, 2022	20.00K	Grant	—	Jun 15
Form 4	—	13.18K	—	—	Jun 17, 2021	13.18K	Grant	—	Jun 16
Form 4	—	13.18K	—	—	Jun 10, 2020	13.18K	Grant	—	Jun 09
Form 4	-73.87%	-8.72M	$12.00	—	Nov 12, 2019	3.08M	Buy-Options	—	Nov 12
Form 4	—	19.78K	—	—	Nov 08, 2019	19.78K	Grant	—	Nov 06
Form 3	—	—	—	—	Nov 06, 2019	—	—	—	—


Form 4	19.53%	450.00K	$20.00	—	Feb 09, 2021	2.75M	Purchase	—	Feb 09
Form 3	—	—	—	—	Feb 04, 2021	—	—	—	—


Form 4	15.27%	270.00K	$17.00	—	Sep 20, 2018	2.06M	Purchase	—	Sep 18
Form 3	—	—	—	—	Sep 13, 2018	—	—	—	—


Form 4	5.95%	150.00K	$36.75	$5.51M	Nov 19, 2019	2.67M	Purchase	—	Nov 15
Form 4	-85.21%	-14.52M	$15.00	—	May 15, 2019	2.52M	Buy-Options	—	May 13
Form 3	—	—	—	—	May 08, 2019	—	—	—	—

Michael Powell's Net Worth

Who is Michael Powell

SEC CIK

Past Insider Trading and Trends

AMARIN CORP PLC\UK

COTHERIX INC

Orexigen Therapeutics, Inc.

Trius Therapeutics Inc

ANESIVA, INC.

HYPERION THERAPEUTICS INC

MARINUS PHARMACEUTICALS INC

HISTOGENICS CORP

Vera Therapeutics, Inc.

Aclaris Therapeutics, Inc.

AERIE PHARMACEUTICALS INC

Inozyme Pharma, Inc.

KALOBIOS PHARMACEUTICALS INC

Entasis Therapeutics Holdings Inc.

Iterum Therapeutics plc

Checkmate Pharmaceuticals, Inc.

Galera Therapeutics, Inc.

Bolt Biotherapeutics, Inc.

Principia Biopharma Inc.

NextCure, Inc.

SYNLOGIC, INC.

THRESHOLD PHARMACEUTICALS INC

aTYR PHARMA INC

ALIMERA SCIENCES INC

Akouos, Inc.

NOVACEA INC

Durata Therapeutics, Inc.

Versartis, Inc.

SEATTLE GENETICS INC /WA

Anthera Pharmaceuticals Inc

Spark Therapeutics, Inc.

Ocera Therapeutics, Inc.

Bicara Therapeutics Inc.


Form 4	—	10.00K	—	—	Jun 07, 2019	10.00K	Grant	—	Jun 05
Form 4	—	10.00K	—	—	Jun 14, 2018	10.00K	Grant	—	Jun 13
Form 4	35.30%	150.00K	$9.75	$1.46M	Jan 30, 2018	574.97K	Grant	—	Jan 26
Form 4	—	18.57K	—	—	Jan 03, 2018	18.57K	Grant	—	Dec 29
Form 4	—	1.43K	—	—	Aug 30, 2017	1.43K	Grant	—	Aug 28
Form 4	—	10.00K	—	—	Sep 06, 2016	10.00K	Grant	—	Jun 29
Form 4	62.75%	1.15M	$7.00	—	Oct 06, 2015	2.97M	Purchase	—	Oct 05 - Oct 06
Form 4	—	7.20K	—	—	Sep 30, 2015	7.20K	Grant	—	Sep 30
Form 3	—	—	—	—	Sep 30, 2015	—	—	—	—


Form 4	—	15.00K	—	—	May 14, 2008	15.00K	Grant	—	May 13
Form 4	—	15.00K	—	—	May 17, 2007	15.00K	Grant	—	May 16
Form 4/A	—	—	—	—	Oct 02, 2006	30.00K	Acq/Dis	—	Sep 26 - Sep 29
Form 4	—	—	—	—	Sep 28, 2006	30.00K	Acq/Dis	—	Sep 26 - Sep 27
Form 4	—	15.00K	—	—	Sep 06, 2006	15.00K	Grant	—	May 25
Form 4	-74.47%	-2.56M	$14.25	-$36.51M	Mar 20, 2006	878.20K	Sale	—	Mar 16
Form 4	—	15.00K	—	—	May 23, 2005	15.00K	Grant	—	May 19
Form 4	0.00%	1.00	$6.27	$6.27	Mar 09, 2005	3.44M	Purchase	—	Mar 08
Form 4	7.30%	234.00K	$7.00	$1.64M	Feb 10, 2005	3.44M	Purchase	—	Feb 09
Form 3	—	—	—	—	Feb 03, 2005	—	—	—	—


Form 4	-87.53%	-13.10M	$14.00	—	May 14, 2015	1.87M	Buy-Options	—	May 12
Form 3	—	—	—	—	May 06, 2015	—	—	—	—


Form 4	151.85%	379.62K	$2.66	$6.67M	Sep 15, 2014	629.62K	Options	—	Sep 11 - Sep 12
Form 3	—	—	—	—	Oct 04, 2012	—	—	—	—


Form 4	-95.06%	-29.17M	$17.00	—	Jul 01, 2020	1.52M	Buy-Options	—	Jun 30
Form 3	—	—	—	—	Jun 25, 2020	—	—	—	—


Form 4	22.00%	400.00K	$6.50	$2.60M	May 15, 2006	2.26M	Purchase	—	May 15
Form 3	—	—	—	—	May 09, 2006	43.21K	—	—	—


Form 4	2.87%	60.00K	$21.00	—	Mar 28, 2014	2.15M	Purchase	—	Mar 26
Form 3	—	—	—	—	Mar 20, 2014	—	—	—	—


Form 4	-7.82%	-56.50K	$7.00	-$395.50K	Dec 16, 2004	685.89K	Sale	—	Dec 14 - Dec 16
Form 4	-3.01%	-22.45K	$7.04	-$157.90K	Dec 09, 2004	742.39K	Sale	—	Dec 07
Form 4	-15.34%	-135.00K	$7.06	-$953.32K	Dec 06, 2004	764.84K	Sale	—	Dec 02 - Dec 06
Form 4	-3.56%	-32.50K	$6.95	-$225.46K	Dec 01, 2004	899.84K	Sale	—	Nov 29 - Dec 01
Form 4	-5.59%	-54.00K	$6.90	-$372.84K	Nov 18, 2004	932.34K	Sale	—	Nov 16
Form 4	-13.13%	-146.00K	$6.79	-$988.72K	Nov 15, 2004	986.34K	Sale	—	Nov 11 - Nov 15
Form 4/A	—	—	—	—	Oct 25, 2004	1.14M	s	—	Sep 23
Form 4	-4.31%	-50.00K	$6.67	-$333.73K	Oct 01, 2004	1.13M	Sale	—	Sep 29
Form 4	-0.85%	-10.00K	$6.92	-$69.20K	Sep 28, 2004	1.18M	Sale	—	Sep 24
Form 4	-7.46%	-94.49K	$6.80	-$644.92K	Sep 23, 2004	1.19M	Sale	—	Sep 21 - Sep 23
Form 4	-4.20%	-55.50K	$6.72	-$372.38K	Sep 17, 2004	1.29M	Sale	—	Sep 15 - Sep 17
Form 4	-1.93%	-26.00K	$6.64	-$171.97K	Sep 03, 2004	1.34M	Sale	—	Sep 02
Form 4	-2.53%	-35.00K	$6.81	-$238.43K	Aug 27, 2004	1.37M	Sale	—	Aug 25 - Aug 27
Form 4	-8.05%	-121.00K	$6.84	-$824.27K	Aug 24, 2004	1.40M	Sale	—	Aug 20 - Aug 24
Form 4	-2.84%	-44.00K	$6.75	-$297.12K	Aug 19, 2004	1.52M	Sale	—	Aug 18 - Aug 19
Form 4	-1.81%	-28.50K	$7.04	-$200.47K	Jun 29, 2004	1.57M	Sale	—	Jun 28 - Jun 29
Form 4	-7.16%	-121.50K	$7.10	-$860.35K	Jun 25, 2004	1.60M	Sale	—	Jun 23 - Jun 25
Form 4	-4.50%	-80.00K	$7.12	-$569.89K	Jun 22, 2004	1.72M	Sale	—	Jun 18 - Jun 22
Form 4	—	10.00K	—	—	May 18, 2004	10.00K	Grant	—	May 17
Form 4	-3.53%	-65.00K	$10.46	-$677.24K	Mar 10, 2004	1.80M	Sale	—	Mar 08 - Mar 09
Form 4	-0.38%	-7.00K	$8.90	-$62.30K	Jan 02, 2004	1.86M	Sale	—	Dec 30
Form 4	-4.51%	-87.25K	$7.16	-$629.59K	Dec 23, 2003	1.87M	Sale	—	Dec 23
Form 4	-2.81%	-56.00K	$7.03	-$392.87K	Dec 10, 2003	1.96M	Sale	—	Dec 08 - Dec 09
Form 4	-0.58%	-11.70K	$6.56	-$76.76K	Dec 05, 2003	2.01M	Sale	—	Dec 03 - Dec 04
Form 4	-7.09%	-153.00K	$6.34	-$968.16K	Dec 02, 2003	2.02M	Sale	—	Nov 28 - Dec 02
Form 4	-4.79%	-108.50K	$6.28	-$680.83K	Nov 26, 2003	2.18M	Sale	—	Nov 24 - Nov 26
Form 4	-15.46%	-414.48K	$6.00	-$2.49M	Nov 19, 2003	2.29M	Sale	—	Nov 18
Form 4	—	—	—	—	May 15, 2003	—	—	—	—


Form 4/A	13.50%	2.10M	$6.13	$12.56M	Dec 22, 2011	17.66M	Options	—	Mar 04
Form 3/A	—	—	—	—	Dec 22, 2011	—	—	—	—


Form 4	-32.86%	-840.41K	$1.48	-$8.62	Dec 30, 2016	1.72M	Sale	—	Sep 12 - Oct 31
Form 4	—	—	$1.26	$15.08K	Jul 13, 2016	11.97K	Options	—	Jul 11
Form 4	—	12.50K	—	—	Jun 15, 2016	12.50K	Grant	—	Jun 14
Form 4	—	10.00K	—	—	Jun 22, 2015	10.00K	Grant	—	Jun 18
Form 4	—	10.00K	—	—	Jun 13, 2014	10.00K	Grant	—	Jun 11
Form 4	-33.00%	-410.02K	—	—	Mar 20, 2014	832.47K	Disposition	—	Mar 18
Form 4	—	20.00K	—	—	Dec 23, 2013	20.00K	Grant	—	Aug 30
Form 4	—	1.28M	$6.03	—	Jul 17, 2013	1.28M	Purchase	—	Jul 15
Form 3	—	—	—	—	Jul 15, 2013	—	—	—	—